The Advent of Artificial Intelligence

artificial intelligence with human head

A cure for malignant mesothelioma remains elusive and is considered one of the most challenging to measure with CT scans due to characteristically complex growth patterns. However, scientists based in Scotland – a country near the top of mesothelioma incidence rates – may have found a way to radically change treating the life-changing, deadly disease.

Artificial intelligence.

Started in 2018, the pilot program involves a prototype imaging system using AI. Developed through a collaboration between the University of Glasgow and Cannon Medical Research Europe, initial results are promising.

Promising results that could revolutionize treatments

Scientists programmed artificial intelligence by inputting more than 100 mesothelioma CT scans. From there, the algorithm found and measured new tumors with acute accuracy, again without the human element, particularly beneficial when it comes to measuring a tumor’s volume. That process alone involves a great deal of time that mesothelioma patients simply don’t have. Automation can detect the most minuscule changes.

Many believe that it could lead to long-awaited advances in what scientists still consider “complex” and “incredibly difficult” disease is diagnosed and subsequent therapeutics.

Vital technological benefits involve greater accuracy and efficiency in the assessment process in a patient’s response to chemotherapy, immunotherapy, and other forms of drug treatments. Simply put, speeding up the diagnostic process that could have a positive impact on the length of survivability. The sooner the diagnoses, the more options exist for treatment.

Time is at a premium for mesothelioma patients and their loved ones. The use of artificial intelligence represents a crucial new chapter in the treatment of this deadly disease. Hopefully, the story leads to numerous happy endings.